The Effect of Breastfeeding Support Provided Via Video-conferencing

Not Applicable

• Conditions: Neonatal Outcomes; Breastfeeding; Anxiety Disorders
• Interventions: Behavioral: Video-conferencing group

• Registration Number: NCT04929561
• Lead Sponsor: Kahramanmaras Sutcu Imam University

Brief Summary

A randomized control trial was made to examine the effects of breastfeeding support given by the video-conferencing method in the early postpartum period on anxiety, breastfeeding self-efficiency, and newborn outcomes.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-08-25
• Status Verified: 2021-06
• Study First Submitted: 2021-06-07
• Study First Submitted QC: 2021-06-15
• Last Update Submitted: 2021-06-15
• Study First Posted: 2021-06-18
• Last Update Posted: 2021-06-18
• Primary Completion: 2021-09-30
• Study Completion: 2021-09-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 78

Inclusion Criteria

Infants;

• Born between 37 and 42 weeks
• Without severe congenital anomalies

Mothers;

• A single live birth
• Were 18 years of age or over
• At least primary school graduate
• Did not have a disease that prevents breastfeeding
• Had internet access at home or on the phone
• Could speak and understand the Turkish language.

Exclusion Criteria

• Situations that cause separation of mother and baby
• Hospitalization of the baby in intensive care
• Inability to answer 3 calls in a video call
• They were determined as those who could not be reached during the home visit for the first and second follow

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Video-conferencing group	Video-conferencing group	The mothers in the video-conferencing group were counseled via video-conferencing a total of six times (three times a week, at equal intervals) during the first 2 weeks after birth. Each interview was approximately 15-20 minutes. In video-conferencing sessions, the breastfeeding position, the mother's grasping the breast, the baby's latch-on, and sucking duration were observed. Mothers' questions were answered and solutions were offered for breastfeeding problems (sore nipple, engorgement, etc.).

Primary Outcome Measures

Name	Time	Method
The mean postpartum maternal anxiety level (mean ± SD)	at 2 weeks and 4 weeks after delivery	The primary outcome of this study was the mean postpartum maternal anxiety level (mean ± SD) of the mothers at 2 weeks and 4 weeks after delivery. Maternal anxiety level was assessed using the Postpartum Specific Anxiety Scale. The scale comprises 51 items and 4 sub-dimensions. It means that those who score 73 and below on the scale have low postpartum anxiety levels, those who score between 74 and 100 have a medium level, and those who score 101 and above have a high level of anxiety.
The mean breastfeeding self-efficacy level	at 2 weeks and 4 weeks after delivery	The other main outcome of the study was the mean breastfeeding self-efficacy level (mean ± SD) measured with the Breastfeeding Self-Efficacy Scale Short Form. The scale is likert type and a total score between 14 and 70 is taken from the scale. The higher the score, the higher the breastfeeding self-efficacy.

Secondary Outcome Measures

Name	Time	Method
Neonatal outcomes-Newborn weight (g)	at 2 weeks and 4 weeks after delivery	Newborn weight (g) was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Hypoglycemia of the newborn	at 2 weeks and 4 weeks after delivery	Hypoglycemia of the newborn was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery.
Neonatal outcomes-Need for phototherapy	at 2 weeks and 4 weeks after delivery	The need for phototherapy was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Respiratory morbidity	at 2 weeks and 4 weeks after delivery	Respiratory morbidity was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Neonatal outcomes-illness requiring hospitalization	at 2 weeks and 4 weeks after delivery	Illness requiring hospitalization was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Food intake other than breast milk	at 2 weeks and 4 weeks after delivery	Food intake other than breast milk was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Neonatal death	at 2 weeks and 4 weeks after delivery	Neonatal death was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery

Trial Locations

Locations (1)

Kahramanmaras Sutcu Imam University; 🇹🇷 Kahramanmaras, Kahramanmaraş, Turkey